PPARA and acute promyelocytic leukemia: Genetic up-regulation of pro-inflammatory factors related to direct growth promotion, generation of genotoxic oxidative stress, immune modulation (28, 29), and metabolic components of endogenous agonists for peroxisome proliferator-activated receptors (PPAR) (30, 31) may be involved in this clinical phenomenon in APL.